|
1
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol.
15(Suppl 2): ii1–ii56. 2013. View Article : Google Scholar :
|
|
2
|
Cuddapah VA, Robel S, Watkins S and
Sontheimer H: A neuro-centric perspective on glioma invasion. Nat
Rev Neurosci. 15:455–465. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suvà ML, Rheinbay E, Gillespie SM, Patel
AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, et
al: Reconstructing and reprogramming the tumor-propagating
potential of glioblastoma stem-like cells. Cell. 157:580–594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caruso C, Carcaterra M and Donato V: Role
of radiotherapy for high grade gliomas management. J Neurosurg Sci.
57:163–169. 2013.PubMed/NCBI
|
|
5
|
Debus C, Waltenberger M, Floca R,
Afshar-Oromieh A, Bougatf N, Adeberg S, Heiland S, Bendszus M, Wick
W, Rieken S, et al: Impact of 18F-FET PET on target volume
definition and tumor progression of recurrent high grade glioma
treated with carbon-ion radiotherapy. Sci Rep. 8:72012018.
View Article : Google Scholar :
|
|
6
|
Yadav VN, Altshuler D, Kadiyala P, Zamler
D, Comba A, Appelman H, Dunn P, Koschmann C, Castro MG and
Löwenstein PR: Molecular ablation of tumor blood vessels inhibits
therapeutic effects of radiation and bevacizumab. Neuro Oncol.
20:1356–1367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song X, Shao Y, Jiang T, Ding Y, Xu B,
Zheng X, Wang Q, Chen X, Gu W, Wu C, et al: Radiotherapy
upregulates programmed death ligand-1 through the pathways
downstream of epidermal growth factor receptor in glioma.
EBioMedicine. 28:105–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ørom UA and Shiekhattar R: Long noncoding
RNAs usher in a new era in the biology of enhancers. Cell.
154:1190–1193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al Chinese Glioma
Cooperative Group: HOTAIR, a cell cycle-associated long noncoding
RNA and a strong predictor of survival, is preferentially expressed
in classical and mesenchymal glioma. Neuro Oncol. 15:1595–1603.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Z, Xu C, Ding B, Gao M, Wei X and Ji N:
Long non-coding RNA MALAT1 promotes proliferation and suppresses
apoptosis of glioma cells through derepressing Rap1B by sponging
miR-101. J Neurooncol. 134:19–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H, Yuan X, Yan D, Li D, Guan F, Dong Y,
Wang H, Liu X and Yang B: Long non-coding RNA MALAT1 decreases the
sensitivity of resistant glioblastoma cell lines to temozolomide.
Cell Physiol Biochem. 42:1192–1201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu
Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al: High expression of
ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is
associated with poor prognosis in neuroblastoma. Int J Oncol.
34:931–938. 2009.PubMed/NCBI
|
|
14
|
Zhu Y, Yu M and Li Z, Kong C, Bi J, Li J,
Gao Z and Li Z: ncRAN, a newly identified long noncoding RNA,
enhances human bladder tumor growth, invasion, and survival.
Urology. 77:510.e511-5152011. View Article : Google Scholar
|
|
15
|
Cayre A, Rossignol F, Clottes E and
Penault-Llorca F: aHIF but not HIF-1alpha transcript is a poor
prognostic marker in human breast cancer. Breast Cancer Res.
5:R223–R230. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thrash-Bingham CA and Tartof KD: aHIF: A
natural antisense transcript overexpressed in human renal cancer
and during hypoxia. J Natl Cancer Inst. 91:143–151. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Q, Matsuura K, Kleiner DE, Zamboni
F, Alter HJ and Farci P: Analysis of long noncoding RNA expression
in hepatocellular carcinoma of different viral etiology. J Transl
Med. 14:3282016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tasharrofi B, Soudyab M, Nikpayam E,
Iranpour M, Mirfakhraie R, Sarrafzadeh S, Geranpayeh L, Azargashb
E, Sayad A and Ghafouri-Fard S: Comparative expression analysis of
hypoxia-inducible factor-alpha and its natural occurring antisense
in breast cancer tissues and adjacent noncancerous tissues. Cell
Biochem Funct. 34:572–578. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rossignol F, de Laplanche E, Mounier R,
Bonnefont J, Cayre A, Godinot C, Simonnet H and Clottes E: Natural
antisense transcripts of HIF-1alpha are conserved in rodents. Gene.
339:121–130. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Span PN, Rao JU, Oude Ophuis SB, Lenders
JW, Sweep FC, Wesseling P, Kusters B, van Nederveen FH, de Krijger
RR, Hermus AR, et al: Overexpression of the natural antisense
hypoxia-inducible factor-1alpha transcript is associated with
malignant pheochromocytoma/paraganglioma. Endocr Relat Cancer.
18:323–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen M and Ren X: New insights into the
biological impacts of immune cell-derived exosomes within the tumor
environment. Cancer Lett. 431:115–122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Samanta S, Rajasingh S, Drosos N, Zhou Z,
Dawn B and Rajasingh J: Exosomes: New molecular targets of
diseases. Acta Pharmacol Sin. 39:501–513. 2018. View Article : Google Scholar
|
|
23
|
Bahrami A, Aledavood A, Anvari K,
Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S
and Avan A: The prognostic and therapeutic application of microRNAs
in breast cancer: Tissue and circulating microRNAs. J Cell Physiol.
233:774–786. 2018. View Article : Google Scholar
|
|
24
|
Lin XJ, Fang JH, Yang XJ, Zhang C, Yuan Y,
Zheng L and Zhuang SM: Hepatocellular carcinoma cell-secreted
exosomal microRNA-210 promotes angiogenesis in vitro and in vivo.
Mol Ther Nucleic Acids. 11:243–252. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kumata Y, Iinuma H, Suzuki Y, Tsukahara D,
Midorikawa H, Igarashi Y, Soeda N, Kiyokawa T, Horikawa M and
Fukushima R: Exosome-encapsulated microRNA-23b as a minimally
invasive liquid biomarker for the prediction of recurrence and
prognosis of gastric cancer patients in each tumor stage. Oncol
Rep. 40:319–330. 2018.PubMed/NCBI
|
|
26
|
Azmi AS, Bao B and Sarkar FH: Exosomes in
cancer development, metastasis, and drug resistance: A
comprehensive review. Cancer Metastasis Rev. 32:623–642. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lugea A and Waldron RT: Exosome-mediated
intercellular communication between stellate cells and cancer cells
in pancreatic ductal adenocarcinoma. Pancreas. 46:1–4. 2017.
View Article : Google Scholar
|
|
28
|
Umezu T, Ohyashiki K, Kuroda M and
Ohyashiki JH: Leukemia cell to endothelial cell communication via
exosomal miRNAs. Oncogene. 32:2747–2755. 2013. View Article : Google Scholar
|
|
29
|
Zhao X, Wu X, Qian M, Song Y, Wu D and
Zhang W: Knockdown of TGF-β1 expression in human umbilical cord
mesenchymal stem cells reverts their exosome-mediated EMT promoting
effect on lung cancer cells. Cancer Lett. 428:34–44. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Richards KE, Zeleniak AE, Fishel ML, Wu J,
Littlepage LE and Hill R: Cancer-associated fibroblast exosomes
regulate survival and proliferation of pancreatic cancer cells.
Oncogene. 36:1770–1778. 2017. View Article : Google Scholar :
|
|
32
|
Ohsh i ma K, Ka nto K, Hat a keya ma K,
Ide T, Wakabayashi-Nakao K, Watanabe Y, Sakura N, Terashima M,
Yamaguchi K and Mochizuki T: Exosome-mediated extracellular release
of polyadenylate-binding protein 1 in human metastatic duodenal
cancer cells. Proteomics. 14:2297–2306. 2014. View Article : Google Scholar
|
|
33
|
Orzan F, De Bacco F, Crisafulli G,
Pellegatta S, Mussolin B, Siravegna G, D'Ambrosio A, Comoglio PM,
Finocchiaro G and Boccaccio C: Genetic Evolution of Glioblastoma
Stem-Like Cells From Primary to Recurrent Tumor. Stem Cells.
35:2218–2228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Godlewski J, Ferrer-Luna R, Rooj AK, Mineo
M, Ricklefs F, Takeda YS, Nowicki MO, Salińska E, Nakano I, Lee H,
et al: MicroRNA signatures and molecular subtypes of glioblastoma:
the role of extracellular transfer. Stem Cell Reports. 8:1497–1505.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abou-El-Ardat K, Seifert M, Becker K,
Eisenreich S, Lehmann M, Hackmann K, Rump A, Meijer G, Carvalho B,
Temme A, et al: Comprehensive molecular characterization of
multifocal glioblastoma proves its monoclonal origin and reveals
novel insights into clonal evolution and heterogeneity of
glioblastomas. Neuro Oncol. 19:546–557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, He L, Lugano R, Roodakker K,
Bergqvist M, Smits A and Dimberg A: IDH mutation status is
associated with distinct vascular gene expression signatures in
lower-grade gliomas. Neuro Oncol. 20:1505–1516. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Darlix A, Deverdun J, Menjot de Champfleur
N, Castan F, Zouaoui S, Rigau V, Fabbro M, Yordanova Y, Le Bars E,
Bauchet L, et al: IDH mutation and 1p19q codeletion distinguish two
radiological patterns of diffuse low-grade gliomas. J Neurooncol.
133:37–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamashita S, Yokogami K, Matsumoto F,
Saito K, Mizuguchi A, Ohta H and Takeshima H: MGMT promoter
methylation in patients with glioblastoma: is methylation-sensitive
high-resolution melting superior to methylation-sensitive
polymerase chain reaction assay. J Neurosurg:. May 4–2018.Epub
ahead of print. View Article : Google Scholar
|
|
39
|
Zhang X, Peng L, Liang Z, Kou Z, Chen Y,
Shi G, Li X, Liang Y, Wang F and Shi Y: Effects of aptamer to
U87-EGFRvIII cells on the proliferation, radiosensitivity, and
radiotherapy of glioblastoma cells. Mol Ther Nucleic Acids.
10:438–449. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tan SK, Pastori C, Penas C, Komotar RJ,
Ivan ME, Wahlestedt C and Ayad NG: Serum long noncoding RNA HOTAIR
as a novel diagnostic and prognostic biomarker in glioblastoma
multiforme. Mol Cancer. 17:742018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
An WG, Kanekal M, Simon MC, Maltepe E,
Blagosklonny MV and Neckers LM: Stabilization of wild-type p53 by
hypoxia-inducible factor 1alpha. Nature. 392:405–408. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang K, Fang C, Yi K, Liu X, Qi H, Tan Y,
Zhou J, Li Y, Liu M, Zhang Y, et al: The role of PTRF/Cavin1 as a
biomarker in both glioma and serum exosomes. Theranostics.
8:1540–1557. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Treps L, Perret R, Edmond S, Ricard D and
Gavard J: Glioblastoma stem-like cells secrete the pro-angiogenic
VEGF-A factor in extracellular vesicles. J Extracell Vesicles.
6:13594792017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zeng AL, Yan W, Liu YW, Wang Z, Hu Q, Nie
E, Zhou X, Li R, Wang XF, Jiang T, et al: Tumour exosomes from
cells harbouring PTPRZ1-MET fusion contribute to a malignant
phenotype and temozolomide chemoresistance in glioblastoma.
Oncogene. 36:5369–5381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao C, Wang H, Xiong C and Liu Y: Hypoxic
glioblastoma release exosomal VEGF-A induce the permeability of
blood-brain barrier. Biochem Biophys Res Commun. 502:324–331. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao C, Wang H, Xiong C and Liu Y: Hypoxic
glioblastoma release exosomal VEGF-A induce the permeability of
blood-brain barrier. Biochem Biophys Res Commun. 502:324–331. 2018.
View Article : Google Scholar : PubMed/NCBI
|
